More DCAT Value Chain Insights

In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.

As we near the end of 2017, what were the major news stories impacting the pharmaceutical industry and the pharmaceutical manufacturing value chain? DCAT Value Chain Insights provides a list of the Top 10 news developments for 2017 from mergers...

Information technology (IT) and digital technologies are touted as key growth drivers in a global economy, but so-called digital fragmentation is seen as a barrier to growth. So what is digital fragmentation, and what is its impact? Digital...

The recent hurricanes in the US, including Puerto Rico, have underscored the role of climate and weather-related issues in supply chains. What is the impact on climate-related issues on the supply chain, and what do companies need to consider...

Digital health is touted as a key tool for patient compliance and knowledge, so what is the state of digital health in the pharmaceutical industry? Health-related mobile applications available to consumers now surpass 318,500, nearly double the...

As the UK seeks to exit the European Union (EU), the pharmaceutical industry has raised concerns over the impact of Brexit. A recent study by the European Federation of Pharmaceutical Industries and Associations (EFPIA), an industry trade...

The European Commission has issued a public consultation to gain feedback on a proposal to allow for a waiver for supplementary protection certificates (SPCs) and other changes in an effort to bolster the competitiveness of European manufacturing...

With the rise of increasingly complex active pharmaceutical ingredients (APIs), specifically biologics and poorly soluble small molecules, the number of parenteral drugs increases as well. Over the past three years, the percentage of parenteral new...

Financing into the biotechnology industry is an important measure for emerging pharmaceutical companies. So how are the dollars flowing thus far in 2017? In tracking US venture-capital funding, $2.2 billion was invested into biotechnology-related...